Skip to main content
SpringerLink
Log in

A Prospective Study on Inflammatory Parameters in Obese Patients After Sleeve Gastrectomy

  • Original Contributions
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Different hormones and peptides involved in inflammation have been studied in and related to obesity. The aim of our work is to assess the variations of different molecules related to inflammation in obese patients during the first year following sleeve gastrectomy. This was a prospective study on patients who underwent sleeve gastrectomy. The variations in different clinical, anthropometric, and analytical parameters related to inflammation were determined and analysed in all patients at the preoperative visit and at the first and fifth days, first and sixth months, and 1 year following surgery. We enrolled 20 patients to the study. The median body mass index (BMI) before intervention was 48.5 kg/m2. With respect to comorbidities, 70 % of the patients had obstructive sleep apnoea syndrome (OSA), 65 % high blood pressure, 45 % dyslipidaemia, and 40 % diabetes mellitus (DM). The median percentage of BMI lost (%BMIL) 1 year after the intervention was 71 %. The dyslipidaemia healing or improvement rate was 100 %, whereas it was 87.5 % for diabetes, 84.6 % for hypertension, and 57.1 % for OSA. During the 1-year postintervention period, the average levels of adiponectin increased, although not significantly, whereas those of leptin significantly decreased. In addition, the blood levels of MCP-1, IL-6, CRP, ferritin, and PAI-1 significantly decreased in that period. Sleeve gastrectomy is a surgical technique that is associated with improvements in body weight and comorbid conditions from the first postoperative months, which lead to significant variations in the levels of different inflammation-related parameters and a decrease in the levels of leptin, IL-6, CRP, MCP-1, ferritin, and serpin (PAI-1).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23:427–36.

    Article  PubMed  Google Scholar 

  2. Rubino F, Gagner M, Gentileschi P, Kini S, Fukuyama S, Feng J, et al. The early effect of the Rou-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg. 2004;240:236–42.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia. 1998;41:1241–8.

    Article  CAS  PubMed  Google Scholar 

  4. Brethauer SA, Heneghan HM, Eldar S, Gatmaitan P, Huang H, Kashyap S, et al. Early effects of gastric bypass on endothelial function, inflammation, and cardiovascular risk in obese patients. Surg Endosc. 2011;25:2650–9.

    Article  PubMed  Google Scholar 

  5. Marti A, Marcos A, Martinez JA. Obesity and immune function relationships. Rev Obes Rev. 2001;2:131–40.

    Article  CAS  Google Scholar 

  6. Wärnberg J, Moreno LA, Mesana MI, Marcos A, AVENA group. Inflammatory mediators in overweight and obese Spanish adolescents. The AVENA Study. Int J Obes Relat Metab Disord. 2004;28:S59–63.

    Article  PubMed  Google Scholar 

  7. Wu DM, Chu NF, Shen MH, Chang JB. Plasma C-reactive protein levels and their relationship to anthropometric and lipid characteristics among children. J Clin Epidemiol. 2003;56:94–100.

    Article  PubMed  Google Scholar 

  8. Bockelbrink A, Stöber Y, Roll S, Vauth C, Willich SN, von der Schulenburg JM. Evaluation of medical and health economic effectiveness of bariatric surgery (obesity surgery) versus conservative strategies in adult patients with morbid obesity. GMS Health Technol Assess. 2008;4:Doc06.

    PubMed Central  PubMed  Google Scholar 

  9. Williams IL, Chowienczyk PJ, Wheatcroft SB, Patel AG, Sherwood RA, Momin A, et al. Endothelial function and weight loss in obese humans. Obes Surg. 2005;15:1055–60.

    Article  PubMed  Google Scholar 

  10. Gokce N, Vita JA, McDonnell M, Forse AR, Istfan N, Stoeckl M, et al. Effect of medical and surgical weight loss on endothelial vasomotor function in obese patients. Am J Cardiol. 2005;95:266–8.

    Article  PubMed  Google Scholar 

  11. Ryan AS, Nicklas BJ. Reductions in plasma cytokine levels with weight loss improve insulin sensitivity in overweight and obese postmenopausal women. Diabetes Care. 2004;27:1699–705.

    Article  PubMed  Google Scholar 

  12. Bastard JP, Jardel C, Bruckert E, Blondy P, Capeau J, Laville M, et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue. J Clin Endocrinol Metab. 2000;85:3338–42.

    CAS  PubMed  Google Scholar 

  13. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448–54.

    Article  CAS  PubMed  Google Scholar 

  14. Havel PJ. Update on adipocyte hormones. Regulation of energy balance and carbohydrate/lipid metabolism. Diabetes. 2004;53:S143–51.

    Article  CAS  PubMed  Google Scholar 

  15. Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, Rahe S, et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes. 2003;52:239–43.

    Article  CAS  PubMed  Google Scholar 

  16. Lichtash CT, Cui J, Guo X, Xen YD, Hsueh WA, Rotter JI, et al. Body adiposity index versus body mass index and other anthropometric traits as correlates of cardiometabolic risk factors. PLoS One. 2013;8(6):e65954.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Chen SC, Huang YF, Wang JD. Hyperferritinemia and hyperuricemia may be associated with liver function abnormality in obese adolescents. PLoS One. 2012;7:e48645.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Cancello R, Henegar C, Viguerie N, Taleb S, Poitou C, Rouault C, et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes. 2005;54:2277–86.

    Article  CAS  PubMed  Google Scholar 

  19. Christiansen T, Richelsen B, Bruun JM. Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes (Lond). 2005;29:146–50.

    Article  CAS  Google Scholar 

  20. Oreopoulos A, Ezekowitz JA, McAlister FA, Kalantar-Zadeh K, Fonarow GC, et al. Association between direct measures of body composition and prognostic factors in chronic heart failure. Mayo Clin Proc. 2010;85:609–17.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Marzullo P, Minocci A, Giarda P, Marconi C, Tagliaferri A. Walker GE, et al. Endocrine: Lymphocytes and immunoglobulin patterns across the threshold of severe obesity; 2013. doi:10.1007/s12020-013-0006-z.

    Google Scholar 

  22. Woelnerhanssen B, Peterli R, Steinert RE, Peters T, Borbély Y, Beglinger C. Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy—a prospective randomized trial. Surg Obes Relat Dis. 2011;7:561–8.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

All authors (Verónica Gumbau, Marcos Bruna, Enrique Canelles, Marcos Guaita, Claudia Mulas, Carla Basés, Isabel Celma, Jose Puche, Goitzane Marcaida, Miguel Oviedo, Antonio Vázquez) declare that they have no conflict of interests in the preparation of this manuscript.

Author information

Authors and Affiliations

  1. Esophago-gastric and Bariatric Surgery Unit, Department of General and Digestive Surgery, Consorcio Hospital General Universitario, Valencia, Spain

    Verónica Gumbau, Marcos Bruna, Enrique Canelles, Claudia Mulas, Carla Basés, Jose Puche, Miguel Oviedo & Antonio Vázquez

  2. Av. Tres Creus, 2, 46014, Valencia, Spain

    Verónica Gumbau

  3. Clinical Analyses Unit, Biomedical Diagnosis Center, Consorcio Hospital General Universitario, Valencia, Spain

    Marcos Guaita, Isabel Celma & Goitzane Marcaida

Authors
  1. Verónica Gumbau
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marcos Bruna
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Enrique Canelles
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marcos Guaita
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Claudia Mulas
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Carla Basés
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Isabel Celma
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jose Puche
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Goitzane Marcaida
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Miguel Oviedo
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Antonio Vázquez
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Verónica Gumbau.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gumbau, V., Bruna, M., Canelles, E. et al. A Prospective Study on Inflammatory Parameters in Obese Patients After Sleeve Gastrectomy. OBES SURG 24, 903–908 (2014). https://doi.org/10.1007/s11695-014-1186-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-014-1186-1

Keywords

Search

Navigation